SunTrust analyst Robyn Karnauskas raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $235.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Vertex (VRTX) PT Raised to $260 at RBC CapitalJanuary 31, 2020 6:35 AM Vertex (VRTX) PT Raised to $255 at JMP SecuritiesJanuary 31, 2020 4:41 AM UPDATE: Baird Downgrades Vertex (VRTX) to Neutral, 'Thesis Has Run its Course'January 31, 2020 4:41 AM After-Hours Stock Movers 01/30: (NAV) (AMZN) (IBM) Higher; (WWE) (KZR) (AMGN) Lower (more...)January 30, 2020 5:48 PM Form 8-K VERTEX PHARMACEUTICALS For: Jan 30January 30, 2020 4:06 PM Vertex Pharma (VRTX) Tops Q4 EPS by 50c, Revenues Beat; Offers FY20 Revenue Guidance Above ConsensusJanuary 30, 2020 4:04 PM Vertex Reports Full-Year and Fourth-Quarter 2019 Financial ResultsJanuary 30, 2020 4:01 PM